SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

DRUG DISCOVERY DEVELOPMENT (DDD)

» Start this Course
(Practice similar questions for free)
Question:

TRIAL OBJECTIVES

Author: LEIGHTON DWIGHT OBILLOS



Answer:

Phase I- limited to determining toxicity at a range of dosages Terminal illnesses- efficacy assessment Phase Il and III- Clinical efficacy in large sample of patients Phase IV- Assess efficacy and side effects in specific patient population


0 / 5  (0 ratings)

1 answer(s) in total